BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27733502)

  • 1. SZGR 2.0: a one-stop shop of schizophrenia candidate genes.
    Jia P; Han G; Zhao J; Lu P; Zhao Z
    Nucleic Acids Res; 2017 Jan; 45(D1):D915-D924. PubMed ID: 27733502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SZGR: a comprehensive schizophrenia gene resource.
    Jia P; Sun J; Guo AY; Zhao Z
    Mol Psychiatry; 2010 May; 15(5):453-62. PubMed ID: 20424623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating genome-wide association study and methylation functional annotation data identified candidate genes and pathways for schizophrenia.
    Qi X; Guan F; Wen Y; Li P; Ma M; Cheng S; Zhang L; Liang C; Cheng B; Zhang F
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109736. PubMed ID: 31425724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SZDB2.0: an updated comprehensive resource for schizophrenia research.
    Wu Y; Li X; Liu J; Luo XJ; Yao YG
    Hum Genet; 2020 Oct; 139(10):1285-1297. PubMed ID: 32385526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SZDB: A Database for Schizophrenia Genetic Research.
    Wu Y; Yao YG; Luo XJ
    Schizophr Bull; 2017 Mar; 43(2):459-471. PubMed ID: 27451428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the primate-specific gene BTN3A2 as an additional schizophrenia risk gene in the MHC loci.
    Wu Y; Bi R; Zeng C; Ma C; Sun C; Li J; Xiao X; Li M; Zhang DF; Zheng P; Sheng N; Luo XJ; Yao YG
    EBioMedicine; 2019 Jun; 44():530-541. PubMed ID: 31133542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Genome and Ancestry Report: An interactive web application for prioritizing clinically implicated variants from genome sequencing data with ancestry composition.
    Lee IH; Negron JA; Hernandez-Ferrer C; Alvarez WJ; Mandl KD; Kong SW
    Hum Mutat; 2020 Feb; 41(2):387-396. PubMed ID: 31691385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
    Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
    Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian framework for multiple trait colocalization from summary association statistics.
    Giambartolomei C; Zhenli Liu J; Zhang W; Hauberg M; Shi H; Boocock J; Pickrell J; Jaffe AE; ; Pasaniuc B; Roussos P
    Bioinformatics; 2018 Aug; 34(15):2538-2545. PubMed ID: 29579179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case.
    Sun J; Jia P; Fanous AH; Webb BT; van den Oord EJ; Chen X; Bukszar J; Kendler KS; Zhao Z
    Bioinformatics; 2009 Oct; 25(19):2595-6602. PubMed ID: 19602527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cross-tissue genetic-epigenetic effects and their patterns in schizophrenia.
    Lin D; Chen J; Perrone-Bizzozero N; Bustillo JR; Du Y; Calhoun VD; Liu J
    Genome Med; 2018 Feb; 10(1):13. PubMed ID: 29482655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PhenoModifier: a genetic modifier database for elucidating the genetic basis of human phenotypic variation.
    Sun H; Guo Y; Lan X; Jia J; Cai X; Zhang G; Xie J; Liang Q; Li Y; Yu G
    Nucleic Acids Res; 2020 Jan; 48(D1):D977-D982. PubMed ID: 31642469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database.
    Xiong Y; Wei Y; Gu Y; Zhang S; Lyu J; Zhang B; Chen C; Zhu J; Wang Y; Liu H; Zhang Y
    Nucleic Acids Res; 2017 Jan; 45(D1):D888-D895. PubMed ID: 27899673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QTLbase: an integrative resource for quantitative trait loci across multiple human molecular phenotypes.
    Zheng Z; Huang D; Wang J; Zhao K; Zhou Y; Guo Z; Zhai S; Xu H; Cui H; Yao H; Wang Z; Yi X; Zhang S; Sham PC; Li MJ
    Nucleic Acids Res; 2020 Jan; 48(D1):D983-D991. PubMed ID: 31598699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of genomic variants and gene expression data in schizophrenia suggests the potential need for adjunctive therapeutic interventions for neuropsychiatric disorders.
    Anirudh Chellappa S; Pathak AK; Sinha P; Jainarayanan AK; Jain S; Brahmachari SK
    J Genet; 2019 Jun; 98(2):. PubMed ID: 31204709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of complementarity of WGCNA and NERI results for identification of modules associated to schizophrenia spectrum disorders.
    Feltrin AS; Tahira AC; Simões SN; Brentani H; Martins DC
    PLoS One; 2019; 14(1):e0210431. PubMed ID: 30645614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Functional Genomics for Systems Genetics in GeneWeaver.org.
    Bubier JA; Langston MA; Baker EJ; Chesler EJ
    Methods Mol Biol; 2017; 1488():131-152. PubMed ID: 27933523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Search for risk genes in schizophrenia].
    Rujescu D
    Nervenarzt; 2017 Jul; 88(7):751-754. PubMed ID: 28429076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. wKinMut-2: Identification and Interpretation of Pathogenic Variants in Human Protein Kinases.
    Vazquez M; Pons T; Brunak S; Valencia A; Izarzugaza JM
    Hum Mutat; 2016 Jan; 37(1):36-42. PubMed ID: 26443060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mega-analysis of Odds Ratio: A Convergent Method for a Deep Understanding of the Genetic Evidence in Schizophrenia.
    Jia P; Chen X; Xie W; Kendler KS; Zhao Z
    Schizophr Bull; 2019 Apr; 45(3):698-708. PubMed ID: 29931221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.